FORS TRAN Share Price Nasdaq
Stocks
FTAI
US34960P1012
Aerospace & Defense
OTC Markets Traded| Market Cap | 2.02TCr 1.73TCr 1.63TCr 1.49TCr 2.78TCr 1,90700Cr 2.79TCr 19TCr 7.47TCr 98TCr 7.57TCr 7.41TCr 3,11000Cr | P/E 2026 * |
34x | P/E 2027 * | 14.7x |
|---|---|---|---|---|---|
| Enterprise Value | 2.24TCr 1.93TCr 1.81TCr 1.65TCr 3.09TCr 2,11800Cr 3.1TCr 21TCr 8.3TCr 1,08500Cr 8.41TCr 8.23TCr 3,45500Cr | EV / Sales 2026 * |
5.74x | EV / Sales 2027 * | 3.41x |
| Free-Float |
98.86% | Yield 2026 * |
0.93% | Yield 2027 * | 0.89% |
Last Transcript : FORS TRAN
| 1 day | +1.85% |
| Manager | Title | Age | Since |
|---|---|---|---|
Joseph Adams
CEO | Chief Executive Officer | 68 | 01/05/2015 |
| Director of Finance/CFO | 36 | 06/03/2026 | |
David Moreno
PSD | President | 36 | 12/02/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Joseph Adams
CHM | Chairman | 68 | 01/05/2016 |
Paul Goodwin
BRD | Director/Board Member | 83 | 01/05/2015 |
Judith Hannaway
BRD | Director/Board Member | 74 | 01/01/2018 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.85% | -3.44% | - | - | 2.02TCr | ||
| +1.09% | -1.59% | +20.73% | +199.18% | 35TCr | ||
| -0.66% | -5.16% | +27.47% | +140.44% | 27TCr | ||
| +0.09% | -2.57% | +38.61% | +594.36% | 17TCr | ||
| -1.44% | -6.84% | +13.23% | +23.90% | 12TCr | ||
| -1.77% | -5.25% | +11.31% | +64.82% | 9.71TCr | ||
| -0.49% | -4.75% | +9.57% | +92.01% | 7.49TCr | ||
| -2.51% | -5.61% | -11.33% | +21.56% | 7.32TCr | ||
| -1.28% | -11.59% | -41.48% | +313.78% | 5.61TCr | ||
| +3.90% | -0.84% | - | - | 5.1TCr | ||
| Average | -0.03% | -4.74% | +8.51% | +181.26% | 14.01TCr | |
| Weighted average by Cap. | -0.10% | -4.04% | +17.69% | +200.22% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 389.81Cr 335.24Cr 315.3Cr 287.83Cr 538.3Cr 37TCr 540.05Cr 3.74TCr 1.45TCr 19TCr 1.46TCr 1.43TCr 60TCr | 640.8Cr 551.09Cr 518.32Cr 473.15Cr 884.91Cr 61TCr 887.77Cr 6.15TCr 2.38TCr 31TCr 2.41TCr 2.35TCr 99TCr |
| Net income | 59Cr 51Cr 48Cr 44Cr 82Cr 5.59TCr 82Cr 566.98Cr 219.16Cr 2.86TCr 222.02Cr 217.16Cr 9.12TCr | 138.55Cr 119.15Cr 112.06Cr 102.3Cr 191.32Cr 13TCr 191.94Cr 1.33TCr 513.6Cr 6.71TCr 520.29Cr 508.92Cr 21TCr |
| Net Debt | 223.48Cr 192.19Cr 180.76Cr 165.01Cr 308.61Cr 21TCr 309.61Cr 2.14TCr 828.46Cr 11TCr 839.26Cr 820.91Cr 34TCr | 166.23Cr 142.96Cr 134.46Cr 122.74Cr 229.56Cr 16TCr 230.3Cr 1.59TCr 616.25Cr 8.05TCr 624.27Cr 610.63Cr 26TCr |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
















